Clinical News
Informatics
Industry News
Medical, Legal, And Practice
Education
Subspecialties
More
Sign In
Breast Imaging
CV
Chest
Emergency
GI
GU
Head & Neck
Interventional
Physics
MSK
Neuro
Nuclear
Pediatric
Radiation Oncology
Nuclear Radiology: Page 37
Hybrid modalities disappoint in bone metastases accuracy
By
Wayne Forrest
Despite the apparent technological advantages of SPECT/CT, PET/CT, and PET/MRI, the three hybrid modalities do not perform appreciably better than planar bone scintigraphy in detecting and diagnosing bone metastases, according to a study published online on 10 August in the
Journal of Nuclear Medicine
.
August 24, 2017
Australia needs space for radioactive waste
By
AuntMinnieEurope.com staff writers
The dwindling amount of space available for storing radioactive waste could have a detrimental effect on Australia's production of radioisotopes for nuclear medicine imaging.
August 22, 2017
JAMA: PET best option to diagnose ischemic heart disease
By
Wayne Forrest
A head-to-head comparison to determine the most accurate modality for diagnosing myocardial ischemia has found that PET outperforms SPECT, coronary CT angiography, and hybrid variations of the three modalities in patients with suspected coronary artery disease, according to a study published online August 16 in
JAMA Cardiology
.
August 20, 2017
BMJ: Euratom withdrawal will put patients at risk
By
AuntMinnieEurope.com staff writers
New concerns have been voiced about the U.K.'s proposed withdrawal from the European Atomic Energy Community (Euratom), as part of the government's "hard" Brexit plan. This move would threaten the medical isotope supply and put patients at risk, according to an article published on 26 July in
BMJ
.
July 26, 2017
Eckert & Ziegler posts increased 2017 profit forecast
By
AuntMinnieEurope.com staff writers
Isotope technology firm Eckert & Ziegler has posted an increased full-year profit forecast for 2017.
July 24, 2017
PET is center of attention at U.K. Alzheimer's conference
By
Wayne Forrest
While PET can accurately detect or exclude Alzheimer's disease by imaging beta-amyloid plaques in the brain, the modality is underutilized in clinical care, according to research presented this week at the Alzheimer's Association International Conference in London.
July 18, 2017
British Nuclear Medicine Society sends Brexit warning
By
AuntMinnieEurope.com staff writers
The British Nuclear Medicine Society is cautioning that Brexit could have a serious adverse effect on the availability of radioactive isotopes for patient healthcare and medical research.
July 16, 2017
Radiotherapy boost based on PET not always helpful
By
Wayne Forrest
Selectively increasing radiotherapy dose in tumor areas with significant uptake of the PET radiotracer F-18 fluoromisonidazole (FMISO) does not necessarily improve outcomes for non-small cell lung cancer patients, according to a phase II study published in the July issue of the
Journal of Nuclear Medicine
.
July 12, 2017
RCR warns over post-Brexit radioisotope access
By
AuntMinnieEurope.com staff writers
The U.K. Royal College of Radiologists (RCR) is seriously concerned about continued access to radioisotopes if the U.K. leaves the European Atomic Energy Community treaty as a result of Brexit.
July 11, 2017
Why Brexit may cause severe radioisotope shortages
By
Frances Rylands-Monk
Deep concerns are emerging among imaging and oncology specialists that Brexit and the U.K.'s subsequent withdrawal from the European Atomic Energy Community treaty will have a huge impact on nuclear medicine services. Unless issues are resolved soon, cancer patients will suffer, they say.
July 11, 2017
DOPA-PET can alter brain tumor therapy decisions
By
Wayne Forrest
The use of the radiopharmaceutical fluorine-18 dihydroxyphenylalanine (F-18 DOPA) with PET imaging can lead to beneficial changes in management plans for patients with brain tumors, according to a study presented by French researchers at the recent Society of Nuclear Medicine and Molecular Imaging meeting.
July 10, 2017
PET agent could advance blood clot imaging
By
AuntMinnieEurope.com staff writers
German researchers are developing an imaging method that uses a ligand labeled with F-18 to target glycoprotein IIb/IIIa receptors, potentially improving the visualization of blood clots in veins and arteries, according to a preclinical study published in the July issue of the
Journal of Nuclear Medicine
.
July 6, 2017
Previous Page
Page 37 of 90
Next Page